NCT03841409View on ClinicalTrials.gov

Peak Plasma Levels of Bupivacaine After an Erector Spinae Block (ESP)

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions
PharmacokineticsAnesthesia, Local
Interventions
OTHER

Collection of blood samples

Nine blood samples will be collected to determine bupivacaine pharmacokinetics at T10min, T20min, T30min, T45min, T60min, T90min, T120min, T180min, and T240min. T0 will be defined as the end of bupivacaine injection.

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03841409 - Peak Plasma Levels of Bupivacaine After an Erector Spinae Block (ESP) | Biotech Hunter | Biotech Hunter